|
Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Or 130C Paragraph 1 Sgb V For The Period From April 1St, 2026 To Usually March 31St, 2028. Active Ingredient Abrocitinib; Atc Code D11ah08; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Betamethasone And Antibiotics; Atc Code D07cc01; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Carglumic Acid; Atc Code A16aa05; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Enoxaparin Sodium; Atc Code B01ab05; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Ethosuximide; Atc Code N03ad01; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Glecaprevir Pibrentasvir; Atc Code J05ap57; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Glycopyrronium Bromide; Atc Code R03bb06; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Insulin Lispro; Atc Code A10ab04; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Lapatinib; Atc Code L01eh01; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Mesalazine; Atc Code A07ec02; Dosage Form Prolonged-Release Tablet; Potency 1200Mg; Pack Size All (Excluding Clinical Packs),Active Ingredient Nintedanib; Atc Code L01ex09; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Pomalidomide; Atc Code L04ax06; Dosage Form Hkp; Potency 1 Mg, 2 Mg, 3 Mg And 4 Mg; Pack Size 14 Pieces (Excluding Clinic Packs),Active Ingredient Pregabalin; Atc Code N02bf02; Dafo Lse And Ret; Potency All; Pack Size All (Excluding Clinical Packs); Dafo Hkp, Tab; Potency 25 Mg And 300 Mg; Pack Size N0 (28 Pieces + Without Clinic Pack); Wkstk 125 Mg; Pckgr N1 (Without Clinic Pck); Wkstk 175 Mg, 200 Mg, 250 Mg And 275 Mg; Pckgr N2 (Without Clinic Pck); Wkstk 125 Mg, 175 Mg, 250 Mg And 275 Mg; Pckgr N3 (Without Clinic Pck);,Active Ingredient Rufinamide; Atc Code N03af03; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Salmeterol And Fluticasone; Atc Code R03ak06; Dosage Form Inhalation Powder; Potency 50Μg/100Μg N1 And 50Μg/100Μg N3; Pack Size All (Excluding Clinical Packs),Active Ingredient Sultiam; Atc Code N03ax03; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Varenicline; Atc Code N07ba03; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Acarbose; Atc Code A10bf01; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Atazanavir; Atc Code J05ae08; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Atomoxetine; Atc Code N06ba09; Dosage Form Hkp; Potency See Pack Size; Pack Size N3 (25 Mg, 40 Mg, 60 Mg, 80 Mg), 56 St (100 Mg, 10 Mg, 18 Mg) (Excluding Clinical Packs),Active Ingredient Cetirizine; Atc Code R06ae07; Dosage Form Lse, Saf, Sir; Potency Lse, Saf, Sir (5 Mg); Pack Size N1, N2 (Excluding Clinical Packs); Dosage Form Loe, Tei, Tro; PotencyLoe, Tei, Tro (10 Mg); Pack Size N1, N2 (Excluding Clinical Packs),Active Ingredient Ciclopirox; Atc Code D01ae14; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Hydromorphone; Atc Code N02aa03; Dosage Form Rek, Ret; Potency 4 Mg, 8 Mg, 16 Mg, 32 Mg; Pack Size 20 Pcs, 50 Pcs,
|
